Found 306 matching trials
Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma PHASE1 This study has 2 parts: a Dose Escalation Part and a Dose Expansion Part.
...
Show More Location
Multiple Locations
Learn More & Join Trial
Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study. PHASE1 The primary hypothesis is that cancer vaccine can convert non-immunogenic g...
Show More Location
National University Hospital
Learn More & Join Trial
Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma PHASE2 This is a prospective, monocenter, single arm, phase II trial in 33 patient...
Show More Location
Netherlands Cancer Institute-Antoni van Leeuwenhoek Ziekenhuis
Learn More & Join Trial
Study of SQZ-AAC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors PHASE1 This is a Phase 1 open-label, multicenter study of the safety and tolerabil...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
GVAX Plus Checkpoint Blockade in Neuroblastoma PHASE1 This research clinical trial is studying the creation and administration of...
Show More Location
Boston Children's Hospital
Learn More & Join Trial
A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma PHASE2 The purpose of this study is to assess the safety and efficacy of the combi...
Show More Location
St George's University Hospitals NHS Foundation Trust
Learn More & Join Trial
Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab PHASE2 Subjects with resectable melanoma will receive neoadjuvant nivolumab follow...
Show More Status
Active Not Recruiting
Location
Duke Cancer Institute
Learn More & Join Trial
Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260) PHASE2 The purpose of this study is to investigate the characteristics of tumors i...
Show More Location
University of Connecticut Health Center
Learn More & Join Trial
Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis PHASE1 Melanoma is the deadliest form of skin cancer and its incidence has doubled...
Show More Location
Clinique Dermatologique/Radiologie Interventionnelle/Urologie/Gynécologie-CHU de Strasbourg/ICANS
Learn More & Join Trial
A Study of Nivolumab in Combination With Ipilimumab in Chinese Participants With Previously Treated Advanced or Recurrent Solid Tumors PHASE1 The purpose of this study is to evaluate the safety and effectiveness of Ni...
Show More Location
Local Institution - 0015
Learn More & Join Trial